Patent Yard Sign in
Expired Canadian patentCanada

Galenical formulations

CA 2124259 C · Owner: Sandoz Ltd. · Inventors: Meinzer, Armin; Vonderscher, Jacky; Fricker, Gerd

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A pharmaceutical composition containing macrolide e.g. a rapamycin compound , in , an emulsion preconcentrate or microemulsion preconcentrate for oral administration. , The carrier medium for the rapamycin compound includes a hydrophilic phase a , lipophilic phase and a surfactant. The composition is stable and provides high absorption efficiency.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 25, 1994 and granted January 10, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 25, 2014.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 25, 2016.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 25, 1994
GrantedJanuary 10, 2012
Term endedMay 25, 2014
Patent numberCA 2124259 C
Classification (IPC)B01J13/00 +2 more

Timeline

Timeline From CIPO dates

1995199719992001200320052007200920112013Application filedMay 25, 1994Patent grantedJan 10, 2012Term endedMay 25, 2014

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.